img

Global Injection Influenza Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Injection Influenza Vaccine Market Insights, Forecast to 2034

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Injection Influenza Vaccine market is expected to reach to US$ 8050 million in 2024, with a positive growth of %, compared with US$ 7635 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Injection Influenza Vaccine industry is evaluated to reach US$ 10970 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Injection Influenza Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Injection Influenza Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application


6 Months to 3 Years
> 3 Years

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Injection Influenza Vaccine plant distribution, commercial date of Injection Influenza Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Injection Influenza Vaccine introduction, etc. Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Injection Influenza Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Injection Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Injection Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Injection Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Injection Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Injection Influenza Vaccine Revenue by Region
2.2.1 Global Injection Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Injection Influenza Vaccine Revenue by Region (2018-2024)
2.2.3 Global Injection Influenza Vaccine Revenue by Region (2024-2029)
2.2.4 Global Injection Influenza Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Injection Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Injection Influenza Vaccine Sales by Region
2.4.1 Global Injection Influenza Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Injection Influenza Vaccine Sales by Region (2018-2024)
2.4.3 Global Injection Influenza Vaccine Sales by Region (2024-2029)
2.4.4 Global Injection Influenza Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Injection Influenza Vaccine Sales by Manufacturers
3.1.1 Global Injection Influenza Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Injection Influenza Vaccine in 2022
3.2 Global Injection Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Injection Influenza Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Injection Influenza Vaccine Revenue in 2022
3.3 Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Injection Influenza Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Injection Influenza Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Injection Influenza Vaccine Sales by Type
4.1.1 Global Injection Influenza Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Injection Influenza Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Injection Influenza Vaccine Revenue by Type
4.2.1 Global Injection Influenza Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Injection Influenza Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Injection Influenza Vaccine Price by Type
4.3.1 Global Injection Influenza Vaccine Price by Type (2018-2024)
4.3.2 Global Injection Influenza Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Injection Influenza Vaccine Sales by Application
5.1.1 Global Injection Influenza Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Injection Influenza Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Injection Influenza Vaccine Revenue by Application
5.2.1 Global Injection Influenza Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Injection Influenza Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Injection Influenza Vaccine Price by Application
5.3.1 Global Injection Influenza Vaccine Price by Application (2018-2024)
5.3.2 Global Injection Influenza Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Injection Influenza Vaccine Market Size by Type
6.1.1 US & Canada Injection Influenza Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Injection Influenza Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Injection Influenza Vaccine Market Size by Application
6.2.1 US & Canada Injection Influenza Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Injection Influenza Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Injection Influenza Vaccine Market Size by Country
6.3.1 US & Canada Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Injection Influenza Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Injection Influenza Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Injection Influenza Vaccine Market Size by Type
7.1.1 Europe Injection Influenza Vaccine Sales by Type (2018-2029)
7.1.2 Europe Injection Influenza Vaccine Revenue by Type (2018-2029)
7.2 Europe Injection Influenza Vaccine Market Size by Application
7.2.1 Europe Injection Influenza Vaccine Sales by Application (2018-2029)
7.2.2 Europe Injection Influenza Vaccine Revenue by Application (2018-2029)
7.3 Europe Injection Influenza Vaccine Market Size by Country
7.3.1 Europe Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Injection Influenza Vaccine Sales by Country (2018-2029)
7.3.3 Europe Injection Influenza Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Injection Influenza Vaccine Market Size
8.1.1 China Injection Influenza Vaccine Sales (2018-2029)
8.1.2 China Injection Influenza Vaccine Revenue (2018-2029)
8.2 China Injection Influenza Vaccine Market Size by Application
8.2.1 China Injection Influenza Vaccine Sales by Application (2018-2029)
8.2.2 China Injection Influenza Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Injection Influenza Vaccine Market Size by Type
9.1.1 Asia Injection Influenza Vaccine Sales by Type (2018-2029)
9.1.2 Asia Injection Influenza Vaccine Revenue by Type (2018-2029)
9.2 Asia Injection Influenza Vaccine Market Size by Application
9.2.1 Asia Injection Influenza Vaccine Sales by Application (2018-2029)
9.2.2 Asia Injection Influenza Vaccine Revenue by Application (2018-2029)
9.3 Asia Injection Influenza Vaccine Sales by Region
9.3.1 Asia Injection Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Injection Influenza Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Injection Influenza Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Injection Influenza Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Injection Influenza Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Overview
11.4.3 Viatris Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Viatris Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AstraZeneca Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hualan Bio Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Bio Recent Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Changchun Institute of Biological Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sinovac Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinovac Recent Developments
11.9 Jiangsu GDK
11.9.1 Jiangsu GDK Company Information
11.9.2 Jiangsu GDK Overview
11.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Jiangsu GDK Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu GDK Recent Developments
11.10 KM Biologics
11.10.1 KM Biologics Company Information
11.10.2 KM Biologics Overview
11.10.3 KM Biologics Injection Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 KM Biologics Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 KM Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Injection Influenza Vaccine Industry Chain Analysis
12.2 Injection Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Injection Influenza Vaccine Production Mode & Process
12.4 Injection Influenza Vaccine Sales and Marketing
12.4.1 Injection Influenza Vaccine Sales Channels
12.4.2 Injection Influenza Vaccine Distributors
12.5 Injection Influenza Vaccine Customers
13 Market Dynamics
13.1 Injection Influenza Vaccine Industry Trends
13.2 Injection Influenza Vaccine Market Drivers
13.3 Injection Influenza Vaccine Market Challenges
13.4 Injection Influenza Vaccine Market Restraints
14 Key Findings in The Global Injection Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Injection Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Injection Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Injection Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Injection Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Injection Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Injection Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Injection Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Injection Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Injection Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Injection Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Injection Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Injection Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Injection Influenza Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Injection Influenza Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Injection Influenza Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Injection Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Injection Influenza Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Injection Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Injection Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Influenza Vaccine as of 2022)
Table 23. Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Injection Influenza Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Injection Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Injection Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Injection Influenza Vaccine Sales Share by Type (2018-2024)
Table 30. Global Injection Influenza Vaccine Sales Share by Type (2024-2029)
Table 31. Global Injection Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Injection Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Injection Influenza Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Injection Influenza Vaccine Revenue Share by Type (2024-2029)
Table 35. Injection Influenza Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Injection Influenza Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Injection Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Injection Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Injection Influenza Vaccine Sales Share by Application (2018-2024)
Table 40. Global Injection Influenza Vaccine Sales Share by Application (2024-2029)
Table 41. Global Injection Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Injection Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Injection Influenza Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Injection Influenza Vaccine Revenue Share by Application (2024-2029)
Table 45. Injection Influenza Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Injection Influenza Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Injection Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Injection Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Injection Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Injection Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Injection Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Injection Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Injection Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Injection Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Injection Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Injection Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Injection Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Injection Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Injection Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Injection Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Injection Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Injection Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Injection Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Injection Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Injection Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Injection Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Injection Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Injection Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Injection Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Injection Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Injection Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Injection Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Injection Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Injection Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Injection Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Injection Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Injection Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Injection Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Injection Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Injection Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Injection Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Injection Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Injection Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Injection Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Injection Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. CSL Company Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Viatris Company Information
Table 123. Viatris Description and Major Businesses
Table 124. Viatris Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Viatris Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Viatris Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Hualan Bio Company Information
Table 133. Hualan Bio Description and Major Businesses
Table 134. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Hualan Bio Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hualan Bio Recent Developments
Table 137. Changchun Institute of Biological Company Information
Table 138. Changchun Institute of Biological Description and Major Businesses
Table 139. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Changchun Institute of Biological Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Changchun Institute of Biological Recent Developments
Table 142. Sinovac Company Information
Table 143. Sinovac Description and Major Businesses
Table 144. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Sinovac Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sinovac Recent Developments
Table 147. Jiangsu GDK Company Information
Table 148. Jiangsu GDK Description and Major Businesses
Table 149. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Jiangsu GDK Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Jiangsu GDK Recent Developments
Table 152. KM Biologics Company Information
Table 153. KM Biologics Description and Major Businesses
Table 154. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. KM Biologics Injection Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. KM Biologics Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Injection Influenza Vaccine Distributors List
Table 160. Injection Influenza Vaccine Customers List
Table 161. Injection Influenza Vaccine Market Trends
Table 162. Injection Influenza Vaccine Market Drivers
Table 163. Injection Influenza Vaccine Market Challenges
Table 164. Injection Influenza Vaccine Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Injection Influenza Vaccine Product Picture
Figure 2. Global Injection Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Injection Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Injection Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Injection Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Injection Influenza Vaccine Report Years Considered
Figure 11. Global Injection Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Injection Influenza Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Injection Influenza Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Injection Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Injection Influenza Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Injection Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Injection Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Injection Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Injection Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Injection Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Injection Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Injection Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Injection Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Injection Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Injection Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Injection Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Injection Influenza Vaccine in the World: Market Share by Injection Influenza Vaccine Revenue in 2022
Figure 29. Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Injection Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Injection Influenza Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Injection Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Injection Influenza Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Injection Influenza Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Injection Influenza Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Injection Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Injection Influenza Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Injection Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Injection Influenza Vaccine Value Chain
Figure 80. Injection Influenza Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries